Thierry François Alain Jean Jousseaume

Title: Thierry François Alain Jean Jousseaume: Innovator in Pharmaceutical Chemistry

Introduction

Thierry François Alain Jean Jousseaume is a notable inventor based in Schaffhausen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that serve as inhibitors for specific biological pathways.

Latest Patents

Jousseaume holds a patent for "Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors." This invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I), wherein the variables are defined in the claims. The compounds developed in this patent are useful as PI3Kβ inhibitors. Furthermore, the invention encompasses pharmaceutical compositions that include these compounds as an active ingredient, as well as their application as a medicament. He has 1 patent to his name.

Career Highlights

Jousseaume is associated with Janssen Pharmaceutica NV, a prominent company in the pharmaceutical industry. His work focuses on innovative solutions that address critical health challenges through the development of new therapeutic agents.

Collaborations

Throughout his career, Jousseaume has collaborated with esteemed colleagues, including Patrick René Angibaud and Olivier Alexis Georges Querolle. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Thierry François Alain Jean Jousseaume is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions, particularly in the area of PI3K-beta inhibitors, highlight the importance of research in developing effective medical treatments.